Introduction {#sec1-1759091417711512}
============

The cerebral cortex possesses the intrinsic ability to compensate, adapt, and reorganize itself in response to environmental stimuli or pathological conditions. The term *neural plasticity* refers to the dynamic and persistent reorganization of cortical properties, including synaptic connection strength, representation patterns, and functional or structural neuronal activity. Several mechanisms are involved in the origin and modulation of neural plasticity, including long-term potentiation (LTP) and long-term depression (LTD), second messenger pathway activation, gene transcription, and morphological changes in neuronal membranes, axons, and postsynaptic cells. Studies aimed at determining when neural plasticity plays a compensatory versus a maladaptive role would be of substantial interest ([@bibr26-1759091417711512]).

Plastic cortical rearrangement is also considered one of the substrates for learning and memory and is known to be involved in major depressive disorder (MDD). Despite a considerable literature, the neurobiology of depression and related cognitive-behavioral changes remains poorly understood, and the evidence supporting the role of impaired cortical plasticity has generally been indirect. Neurotrophic changes, including the loss of pyramidal neurons ([@bibr81-1759091417711512]) and glial cells in the dorsolateral prefrontal cortex (dlPFC; [@bibr82-1759091417711512]) in addition to a reduction in gamma-aminobutyric acid (GABA)-ergic connections in the hippocampus ([@bibr100-1759091417711512]), have been observed in *postmortem* studies.

Other evidence is provided by studies using animal models of depression and chronic stress ([@bibr65-1759091417711512]). The abnormal chronic activation of the hypothalamic-pituitary-adrenal axis can cause atrophy at the level of the PFC and hippocampus, and these data provide support for the hypothesis that exposure to chronic stress leads to negative effects, including structural modifications of the central nervous system (CNS; [@bibr68-1759091417711512]). In this context, stress-related cortical atrophy is frequently observed in patients with MMD and is particularly prevalent at the level of the frontal, medial temporal, and limbic areas ([@bibr103-1759091417711512]), even in subjects with subclinical depressive symptoms ([@bibr108-1759091417711512]). A reduction in the number of synapses within the dlPFC ([@bibr51-1759091417711512]) in combination with indirect signs of disrupted synaptic signaling processes ([@bibr42-1759091417711512]; [@bibr40-1759091417711512]) indicates that abnormal synaptic functioning is involved in depressive disorders. In particular, impaired cortical activity ([@bibr48-1759091417711512]) and the dysregulation of the connectivity between the PFC and limbic regions have been observed ([@bibr80-1759091417711512]), suggesting the loss of physiological phenomena including cortical excitability and plasticity.

The pathophysiological picture of depression becomes more complex when considering the late-onset form of depression. In patients in whom depression appears later in life ([@bibr6-1759091417711512]), the typical clinical presentations include psychomotor retardation, difficulty at work, apathy, lack of insight, and executive dysfunction. These clinical symptoms, in combination with neuroimaging evidence indicating vascular white matter lesions, support the "vascular depression" (VD) hypothesis. It has been hypothesized that cognitive-behavioral and mood abnormalities reflect ischemic disruption at the level of the dlPFC or the dorsal portion of the head of the caudate nucleus, which are structures that have been implicated in mood-affect regulation and cognition ([@bibr31-1759091417711512]; [@bibr6-1759091417711512]).

Finally, synaptic plasticity-related dysfunction is also viewed as an early event during the development and course of neurological disorders, and depression and other neuropsychiatric symptoms are frequently found to be comorbid manifestations or early symptoms of a more disabling condition, such as Alzheimer's disease ([@bibr73-1759091417711512]; [@bibr12-1759091417711512]), vascular dementia ([@bibr74-1759091417711512]; [@bibr76-1759091417711512]), and atypical Parkinsonism ([@bibr15-1759091417711512]). These symptoms may even present in the preclinical or early stages of these diseases ([@bibr7-1759091417711512], [@bibr8-1759091417711512], [@bibr9-1759091417711512]; [@bibr58-1759091417711512]; [@bibr77-1759091417711512]; [@bibr60-1759091417711512]).

Transcranial Magnetic Stimulation: Basic Principles and Applications for Exploring the Neurochemical Correlates of Neural Plasticity {#sec2-1759091417711512}
====================================================================================================================================

Among neurophysiological techniques, transcranial magnetic stimulation (TMS) was originally introduced as a valuable noninvasive tool that was specifically useful for evaluating excitability in the primary motor cortex (M1) and conductivity along the cortical-spinal tract. Nevertheless, today, the applications involving TMS go well beyond the simple assessment of the pyramidal tract ([@bibr76-1759091417711512]). Indeed, TMS can be used to provide novel insights into the pathophysiology of the circuitries underlying neurological and psychiatric diseases, to probe the *in vivo* excitability and plasticity of the human brain, and to assess the functional integrity of intracortical neuronal and callosal fibers ([@bibr54-1759091417711512]; [@bibr20-1759091417711512]; [@bibr73-1759091417711512], [@bibr74-1759091417711512]; [@bibr58-1759091417711512], [@bibr59-1759091417711512]). TMS is well suited for studies aimed at exploring and monitoring motor system impairment during the preclinical phase of several neurological disorders ([@bibr15-1759091417711512]) or systemic diseases involving the CNS ([@bibr75-1759091417711512]; [@bibr10-1759091417711512]). Moreover, when integrated with other neurophysiological techniques (e.g., electroencephalography---EEG) or structural and functional imaging, TMS also allows the exploration of connectivities across motor and nonmotor areas ([@bibr47-1759091417711512]; [@bibr53-1759091417711512]). Finally, because it can be used to evaluate the effects of drugs that are agonists or antagonists for specific neurotransmitters, TMS can selectively test the activity of glutamatergic, GABAergic, monoaminergic, and cholinergic central circuits (e.g., so called *pharmaco-TMS*; [@bibr118-1759091417711512]).

In this article, we aim to critically and systematically review the literature regarding the use of TMS to probe cortical excitability and neural plasticity in depressive disorders.

Technical principles and brief description of a standard TMS exam {#sec3-1759091417711512}
-----------------------------------------------------------------

TMS is based on Faraday's law of electromagnetic induction to activate cortical neurons ([@bibr5-1759091417711512]). A transducing coil attached to a high-voltage, high-current discharge system produces a strong time-varying and short-lasting magnetic field at right angles to the stimulation coil ([@bibr49-1759091417711512]). When the stimulation coil is placed tangential to the head, the magnetic field penetrates the scalp and skull with minimal attenuation and induces a secondary eddy current in conductive intracranial tissue. The electrical field in the tissue is oriented perpendicular to the magnetic field and opposite the direction of the electrical current in the stimulation coil ([@bibr46-1759091417711512]; [@bibr87-1759091417711512]). The two following coil shapes are most commonly used: a figure-eight-shaped coil and a circular coil. The former provides a more focal stimulation, which allows for fairly detailed mapping of cortical representations, while the latter induces a more widely distributed electric field, which is desirable when evaluating central motor conduction times.

A standard examination involves bilateral recordings from distal limb muscles while the patient is seated or lying on a bed or armchair. Motor evoked potentials (MEPs) are produced by stimulating M1 at the optimum scalp position to elicit motor responses in the contralateral target muscles. MEPs are usually recorded using bipolar surface electrodes (e.g., Ag/AgCl cup electrodes) and a belly tendon montage ([@bibr46-1759091417711512]). During TMS, the operator can control the intensity of the current flowing through the coil and thereby change the magnitude of both the induced magnetic field and the secondarily induced electrical field. In addition to controlling its intensity and focus, the operator can also manipulate the frequency and interstimuli interval of the delivered stimuli, which together critically determine the effects of TMS on the targeted brain region. Indeed, TMS can be delivered as a single pulse, as a pair of stimuli applied to the same or different brain areas, as paired cortical and peripheral stimuli, or as trains of repetitive stimuli. Anatomically precise localization of the stimulus can be achieved by using a stereotactic neuro-navigational system ([@bibr54-1759091417711512]).

Single-pulse TMS {#sec4-1759091417711512}
----------------

A single TMS pulse applied an adequate stimulator intensity to M1 elicits a MEP in the contralateral target muscles ([@bibr34-1759091417711512]). The MEP latency and central motor conduction time are considered indexes of the integrity of cortical-spinal pathways, whereas the MEP amplitude is used to measure the excitation state of the neurons connecting the motor cortex to the muscles ([@bibr87-1759091417711512]). The resting motor threshold (rMT), when defined according to the recommendations of the International Federation of Clinical Neurophysiology Committee ([@bibr87-1759091417711512]), is considered a global parameter of brain excitability because it is a compound measure of the membrane excitability of cortical-spinal neurons, of neural inputs into pyramidal cells within the cortex, and of spinal motor neurons, neuromuscular junctions, and muscles ([@bibr115-1759091417711512]; [@bibr86-1759091417711512]). The stimulus--response curve between TMS stimulus intensity and MEP amplitude provides another useful measurement of excitation ([@bibr85-1759091417711512]).

Applying TMS after a brief period of exercise provides valuable information regarding the cortical excitability and intracortical synaptic reorganization that underlie motor learning ([@bibr16-1759091417711512]). In particular, in normal subjects, postexercise facilitation is defined as a period of increased motor excitability that occurs after transient muscle activation and decays to baseline over 2 to 4 min. This phenomenon is thought to originate in the cortex because transcranial electric stimulation fails to elicit exercise facilitation when cortical-spinal cells are stimulated at their proximal axons ([@bibr90-1759091417711512]).

The ability to perform focal stimulation using butterfly coils has allowed mapping studies to determine muscle representation. The results can then be used to determine the center of gravity of a motor representation ([@bibr107-1759091417711512]) that underlies a type of cortical plasticity ([@bibr26-1759091417711512]). Experiments have repeatedly shown that neurons can assume the properties of nearby neurons in other, usually adjacent, areas. Cortical map plasticity has been demonstrated in both animal models and human cortex, as have changes in motor maps, such as those resulting from exercise or practicing movement tasks ([@bibr25-1759091417711512]).

Applying a suprathreshold TMS pulse to M1 during a tonic voluntary contraction of contralateral muscles suppresses electromyographic activity in those muscles for a few hundred milliseconds ([@bibr19-1759091417711512]). This phenomenon, called the contralateral silent period (CSP), can be exploited to functionally measure intracortical inhibitory circuits ([@bibr14-1759091417711512]), which are mediated mainly by GABA-B transmission ([@bibr95-1759091417711512]). If the pulse is delivered to the ipsilateral M1, an electromyographic silence that lasts approximately 30 ms and is called the ipsilateral silent period (iSP) can be recorded. The iSP is thought to reflect the ability of the motor cortex to excite the inhibitory interneurons in its contralateral counterpart, and it seems to be induced via transcallosal pathways ([@bibr41-1759091417711512]).

Paired-pulse TMS {#sec5-1759091417711512}
----------------

Inhibitory and excitatory interneuronal activity within the human cortex can be explored noninvasively using a paired-pulse TMS paradigm ([@bibr57-1759091417711512]; [@bibr117-1759091417711512]). The conventional protocol uses a "conditioning stimulus" (subthreshold) followed by a "test stimulus" (suprathreshold). By varying the intensity of the conditioning stimulus and the interval between the pair of TMS pulses (the interstimulus interval---ISI), a number of measures of intracortical interneuronal function and interaction can be obtained. At an ISI of 1--4 ms, the conditioning stimulus suppressed the MEP amplitude, a phenomenon that has been called short-latency intracortical inhibition (SICI). At a longer ISI (7--20 ms), the stimulus results in intracortical facilitation of motor responses ([@bibr57-1759091417711512]). The mechanisms underlying these phenomena are thought to reflect the activity of distinctive neurochemical circuits. Hence, while SICI is likely mediated by GABA-A interneuron activity ([@bibr33-1759091417711512]), facilitation is more complex ([@bibr36-1759091417711512]), although it does appear to be produced mainly by the activation of glutamatergic cells ([@bibr57-1759091417711512]; Paulus et al., 2008).

Sensory-motor modulation {#sec6-1759091417711512}
------------------------

TMS can be used to test the functional connectivity of different cortical areas and monitor how connectivity changes over time. For instance, the short-latency afferent inhibition (SAI) of MEP responses reflects the sensory stimuli-mediated inhibitory modulation of M1 ([@bibr102-1759091417711512]). This effect depends on the time that elapses between the peripheral nerve electrical stimulus and the TMS pulse, and it typically occurs at an ISI of 20 ms ([@bibr88-1759091417711512])*.* SAI may represent a neurophysiological correlate of central cholinergic activity *in vivo* because it is reduced or abolished by the muscarinic receptor antagonist scopolamine ([@bibr33-1759091417711512]) and positively modulated by acetylcholine ([@bibr35-1759091417711512]).

TMS for measuring neural plasticity {#sec7-1759091417711512}
-----------------------------------

Changes in cortical plasticity can be induced by and studied using a repetitive TMS (rTMS) paradigm. Repetitive TMS can be used to modify the excitability of the human cortex in a predictable manner, with low frequencies (stimulus rates \<1 Hz) usually used to inhibit and high frequencies (5--20 Hz) used to induce excitation in the stimulated cortical area ([@bibr18-1759091417711512]). The changes in excitability that are produced by rTMS share several characteristics with the induction of LTP and LTD by tetanic stimulation in cortical slices ([@bibr106-1759091417711512]). Indeed, most, but not all, rTMS paradigms are N-Methyl-D-aspartate (NMDA)-receptor activity dependent ([@bibr17-1759091417711512]) and modulated by prior synaptic activation ([@bibr50-1759091417711512]), and the induced change in MEP amplitude is dependent on the frequency of stimulation ([@bibr37-1759091417711512]). Plasticity involves the rapid down-regulation of GABA-related inhibitory circuits and short-term changes in synaptic efficacy, which are dependent on sodium and calcium channels ([@bibr116-1759091417711512]). The rTMS-induced long-lasting reduction in SICI appears to involve the activation of NMDA receptors and is probably associated with a LTP-like mechanism. However, rTMS is also able to avoid saturation by inducing LTD-like responses that decrease the efficacy of connections between synapses. LTD refers to a prolonged use-dependent decrease in the strength of excitatory synapses and is predominantly mediated by the activation of synaptic NMDA receptors or metabotropic glutamate receptors at the level of hippocampal CA3:CA1 synapses ([@bibr45-1759091417711512]). However, because rTMS affects a wide range of cell types that possess a variety of properties, obtaining a comprehensive understanding of the induction of LTP or LTD is not enough to determine the actual impact of rTMS on the human brain. The powerful role of TMS in modulating human neuroplasticity is of crucial clinical relevance because it could be used to support plasticity where it is needed or, conversely, to down-regulate neuronal excitability where it such excitation is found to be maladaptive. However, TMS can also be used to induce long-lasting effects in cerebral regions outside M1, such as the prefrontal areas or the cerebellum ([@bibr54-1759091417711512]).

These findings reflect an interest in identifying therapeutic applications in neurological or psychiatric disorders. This interest is also demonstrated by the development of paired associative stimulation (PAS), which is considered a repetitive application of SAI ([@bibr99-1759091417711512]). The PAS protocol includes applying an electrical stimulus to a peripheral nerve (usually the median nerve) and then a single TMS pulse over the hand area of M1. PAS induces long-lasting LTP-/LTD-like changes in sensory-motor pathways, which are considered a marker of motor cortex plasticity.

Finally, new rTMS paradigms have recently been developed to facilitate further investigations into cortical excitability and synaptic plasticity. For example, theta burst stimulation (TBS) and quadripulse stimulation (QPS) can be used to produce neuroplastic effects that range broadly from MEP suppression to MEP facilitation, depending on the interval of the pulses within a burst. Moreover, they can be used to measure so called *metaplasticity*, which refers to the ability of a synapse to undergo a second plastic change subsequent to a recent induction of plasticity (Yger and Gilson, 2015).

Data Source and Selection {#sec8-1759091417711512}
=========================

We performed a PubMed-based literature review to identify all studies that have been published on neural plasticity and MDD. The following keywords were used: "transcranial magnetic stimulation," "plasticity," and "depression." The following data were extracted: (a) study design; (b) patient characteristics, such as sample size and the age, gender, laterality, diagnostic criteria, and drug exposure of participants; (c) TMS features; and (d) results and main translational findings. In an initial search performed using the above-mentioned keywords, a total of 212 articles were screened. We then excluded articles on TMS and plasticity that were performed in healthy subjects or studies conducted using animals because their content did not fit the aim of this review. Moreover, we excluded preliminary or low-quality data to avoid drawing misleading conclusions. We also excluded articles that were not research studies (e.g., reviews, letters to the Editor, and commentaries) and papers published in language other than English. Publications that addressed only the treatment of psychiatric disorders were also excluded. Finally, we reviewed the articles listed in the reference sections of the selected papers to locate any further relevant data. We identified 25 studies as a result of this process.

[Tables 1](#table1-1759091417711512){ref-type="table"} and [2](#table2-1759091417711512){ref-type="table"} provide a summary of the main findings of the identified TMS studies related to cortical excitability and synaptic plasticity, respectively, in depressive disorders. [Figure 1](#fig1-1759091417711512){ref-type="fig"} provides a summary overview of the main findings regarding the use of TMS techniques and the implications of these findings for therapeutic strategies. Table 1.TMS Studies of Cortical Excitability in Depressed Subjects.StudyNumber of participants (M/F)Age (years) mean ± *SD* (or range)Diagnosis/ diagnostic criteria usedDrug exposureMeasures of plasticity investigatedResults in depressed subjectsMain translational findings[@bibr77-1759091417711512]16 VD (NR) *vs* 11 VCI-ND (NR) *vs* 15 controls (NR)68.1 ± 8.6 *vs* 70.0 ± 7.0 *vs* 63.8 ± 7.2DSM-IV-TRNrMT CSP Paired-pulse curve▾ rMT ▾ CSP ▪ SICI ▪ ICFThe mechanisms that enhance the risk of dementia in VD might be related to either subcortical vascular lesions or a lack of compensatory functional cortical changes.[@bibr105-1759091417711512]60 patients (19/41) *vs* 21 controls (11/10)37 *vs* 28MDD subtypes/ DSM-VNrMT CSP Paired-pulse curve▴ rMT ▾ CSP ▾ SICI ▴ ICFCortical excitability, glutamatergic and GABA-ergic balance are neurophysiological markers of different subtypes of depression.[@bibr27-1759091417711512]11 VD (6/5) *vs* 11 MDD (5/6) *vs* 11 controls (6/5)67.72 ± 3.29 *vs* 57.18 ± 7.12 *vs* 67.36 ± 3.75DSM-IV-TRYrMT CSP Paired-pulse curve▴ rMT (L) ▴ CSP (R) ▪ SICI ▪ ICFDistinctive TMS patterns between late-onset depression with subcortical vascular disease and early-onset drug-resistant MDD. Possible drug effects of inhibitory measures.[@bibr30-1759091417711512]24 patients (10/14) *vs* 22 controls (11/11)13.9 ± 2.1 *vs* 13.8 ± 2.2MDD/K-SADS-PL and CDRS-RNrMT CSP Paired-pulse curve▪ rMT ▾CSP (L) ▪ SICI ▴ICFNeurophysiological abnormalities are also present in children and adolescents.Bella et al., 201115 VD (7/8) *vs* 10 VCI-ND (6/4) *vs* 10 controls (5/5)70.5 ± 6.6 *vs* 70.8 ± 6.3 *vs* 67.7 ± 3.9DSM-IV-TRNrMT CSP Paired-pulse curve▪ rMT ▪ CSP ▾ SICI ▪ CSPThe neurophysiological mechanisms underlying VD differ from those reported in MDD and seem to be similar to those in patients with subcortical ischemic vascular disease.[@bibr62-1759091417711512]60 patients (22/38) *vs* 25 controls (12/13)47.2 ± 11.2 *vs* 43.8 ± 8.9MDD/DSM-IVYrMT CSP Paired-pulse curve▴ rMT (L) ▾ CSP ▾ SICI ▪ ICFCortical excitability and glutamatergic and GABAergic balance are neurophysiological markers of different subtypes of depression.[@bibr69-1759091417711512]91 patients (39/52) No control group46.1 ± 10.5MDD/DSM-IVYrMT▪ rMTA trend toward a lower rMT on the left hemisphere. Probable influence of long-term benzodiazepine intake.[@bibr61-1759091417711512]35 patients (14/21) *vs* 35 controls (17/18)56 ± 2.8 *vs* 43MDD/DSM-IVYrMT CSP Paired-pulse curve▴ rMT (L) ▾ CSP (L) ▾ SICI (L) ▾ ICF (L)Significant reduction of excitability of both inhibitory and facilitatory inputs in the left hemisphere that correlates with depression severity.[@bibr63-1759091417711512]15 patients (9/6) *vs* 15 controls (11/4)36.8 ± 9.1 *vs* 35.1 ± 9.2Bipolar disorderYCSP Paired-pulse curve transcallosal inhibition▾ CSP ▾ SICI ▪ ICF ▾ iSPBipolar patients exhibited impairment of inhibitory pathways[@bibr3-1759091417711512]20 patients (14/6) *vs* 20 controls (14/6)42.9 ± 11.9 *vs* 44 ± 14.6MDD/DSM-IVNrMT CSP Paired-pulse curve▾ rMT (R) ▾ CSP ▾ ICI (B)Reduction of GABAergic TMS parameters, suggesting a central inhibitory deficit in medication-free MDD patients.[@bibr43-1759091417711512]60 patients (NR) No control group-MDD (unipolar or bipolar)/DSM- IVYrMT CSP Paired-pulse curve rTMS▴ rMT (R) ▾ CSP ▾ ICI (L)Relationship between excitability of the right hemisphere and the severity of psychopathology, and between inhibition in the left hemisphere and poor response to rTMS.[@bibr66-1759091417711512]8 patients (5/3) *vs* 8 controls (6/2)46.8 *vs* 44.9MDD/DSM-IVNrMT Paired-pulse curve▴ rMT (L) ▴ SICI (L) ▾ ICF (L)Significant interhemispheric difference that correlates with depression severity.[@bibr98-1759091417711512]16 patients (4/12) *vs* 19 controls (6/13)43.1 ± 8.9 *vs* 40.2 ± 11.5MDD/DSM-IVYrMT CSP▴ CSPData do not support motor retardation due to a dopaminergic parkinsonian-like mechanism.[@bibr1-1759091417711512]10 patients (7/3) *vs* 10 controls (6/4)39.4 ± 11.3 *vs* 39.7 ± 6.7MDDYrMT CMCTNeither asymmetry nor variationMotor cortex as an intriguing window into neuropsychiatric disorders.[^1] Table 2.Investigations of Neural Plasticity That Used TMS-Related Protocols in Patients With Depression.StudyNumber of participants (M/F)Age (years) mean ± *SD* (or range)Diagnosis/ diagnostic criteria usedDrug exposureMeasures of p lasticity investigatedResults in depressed subjectsMain translational findings[@bibr56-1759091417711512]27 patients (15/12) *vs* 27 controls (14/13)19-58 *vs* 18-55MDD/ICD-10YPAS▾ LTP-like plasticity restored after remissionState-dependent synaptic plasticity as a treatment target.[@bibr79-1759091417711512]23 patients (10/13) *vs* 23 controls (NR)38.0 ± 12.8 *vs* 38.5 ± 13.1MDD (20) and bipolar disorder (3)/DSM-IVYPAS▾ LTP-like plasticityAltered plasticity in depression might influence learning or response to treatment.[@bibr97-1759091417711512]12 drug-resistant MDD (8/4) *vs* 10 drug-free patients (6/4)50.5 ± 8.7 *vs* 55.6 ± 8.8MDD/DSM-IV-TRYrMT, paired-pulse curve before and after 10-Hz rTMS to the dlPFCRestored rMT asymmetry and paired-pulse curve imbalanceBrain stimulation techniques are clinically effective for modulating altered excitability and plasticity in drug-resistant MDD.[@bibr30-1759091417711512]8 patients (1/7) No control group16.1 ± 1.1MDD/ K-SADS-PL and CDRS-RYrMT after 10-Hz rTMS to the left M1▾ rMTrTMS is safe for studying and treating affective disorders in children.[@bibr4-1759091417711512]13 patients (1/12) *vs* 14 controls (2/12)36.3 ± 12.9 *vs* 33.7 ± 7.1MDD/DSM-IVYrMT before and after 1-Hz rTMS to the left M1▪ rMT baseline ▴ rMT bilateral after rTMSBrain stimulation techniques are valid tools for restoring plasticity[@bibr83-1759091417711512]10 patients (4/6) *vs* 13 controls (4/9)48.3 ± 12.8 *vs* 35.1 ± 7.9MDD (unipolar or bipolar)/DSM-IVYPostexercise facilitation▾ facilitationFatigue as a phenomenon of cortical origin in depression.[@bibr93-1759091417711512]10 patients (2/8) *vs* 10 controls (3/7)41.1 ± 10.9 *vs* 39.3 ± 10.8MDD (unipolar or bipolar)/DSM-IVYPostexercise facilitation▾ facilitationFatigue as a phenomenon of cortical origin in depression.[@bibr104-1759091417711512]10 patients (5/5) No control group52MDD/DSM-IVNrMT after 20-Hz rTMS to the left dlPFC▾ rMTBrain stimulation techniques are valid tools for restoring plasticity.[@bibr90-1759091417711512]10 patients (NR) *vs* 18 controls (NR)42 *vs* 42MDD (unipolar or bipolar)/ DSM-III-TRNPostexercise facilitation▾ facilitationNeurophysiological correlates of fatigue and motor inertia in depression.[^2] Figure 1.Imbalance in the "depressed brain": a summary overview of the main findings related to TMS techniques and their implications for therapeutic strategies. TMS = transcranial magnetic stimulation; GABA = gamma-amino-butyric acid; MDD = major depressive disorder; rMT = resting motor threshold; LTP = long-term potentiation.

TMS in Depression {#sec9-1759091417711512}
=================

Global Cortical Excitability and Interhemispheric Asymmetry {#sec10-1759091417711512}
-----------------------------------------------------------

Studies that used rMT in depression ([@bibr1-1759091417711512]; [@bibr61-1759091417711512]; [@bibr4-1759091417711512]; [@bibr69-1759091417711512]) revealed that in these individuals, there is a global reduction in cortical excitability in the frontal cortex ([@bibr66-1759091417711512]; [@bibr43-1759091417711512]; [@bibr62-1759091417711512]; [@bibr97-1759091417711512]; [@bibr27-1759091417711512]; [@bibr30-1759091417711512]; [@bibr105-1759091417711512]), an interhemispheric imbalance between the prefrontal and motor cortices that manifested as reduced excitability in the left hemisphere ([@bibr66-1759091417711512]; [@bibr43-1759091417711512]; [@bibr62-1759091417711512]; [@bibr97-1759091417711512]; [@bibr27-1759091417711512]) or increased excitability in the right hemisphere ([@bibr3-1759091417711512]). In one study that investigated interhemispheric asymmetry in the prefrontal and motor cortices, 1 Hz (inhibitory) rTMS was applied to the left M1, and the results showed that the rTMS reduced cortical excitability in the ipsilateral side but did not induce any change (i.e., an increase in excitability) in the right hemisphere ([@bibr4-1759091417711512]). These data suggest that normal interhemispheric modulation had been lost in these individuals.

In other investigations, rMT was reevaluated after rTMS. In one study, high-frequency rTMS was applied to the left prefrontal area, and the results showed that treatment was associated with a significant increase in cortical excitability in the ipsilateral hemisphere ([@bibr104-1759091417711512]). In line with these results, another recent study showed that applying high-frequency rTMS to the left dlPFC for 1 month reduced the difference in excitability between the left and right hemispheres ([@bibr97-1759091417711512]) and was associated with clinical improvements that persisted over time ([@bibr28-1759091417711512]).

Measures of Cortical Inhibition {#sec11-1759091417711512}
-------------------------------

Unlike measures of excitation, conflicting results have emerged regarding indexes of inhibition, namely CSP and SICI. In particular, in some studies, patients with either unipolar or bipolar depression have a prolonged CSP ([@bibr98-1759091417711512]), while other studies, both a reduced CSP and SICI were observed ([@bibr43-1759091417711512]; [@bibr3-1759091417711512]; [@bibr61-1759091417711512]). Shortened CSP has also been reported in patients with a previous diagnosis of MDD and in those with treatment-resistant depression. Interestingly, only the latter group exhibited significantly reduced SICI ([@bibr62-1759091417711512]). These results are consistent with the "cortical disinhibition" hypothesis, in which GABAergic transmission is involved in the pathophysiology of depression, as was previously suggested by animal, neurochemical, and neuroimaging studies ([@bibr11-1759091417711512]; [@bibr29-1759091417711512]).

The influences of physiological, technical, and experimental factors should be taken into account because variability in these measures has been observed even in healthy individuals. For instance, because CSP duration is known to be dependent on stimulus intensity and type of stimulating coil that is used ([@bibr52-1759091417711512]), these parameters need to be considered. Moreover, different TMS methods have been employed, and differences in the ages, clinical presentation, and severity of included patients as well as the effects of neuroactive drugs on measures of cortical excitation and inhibition may contribute to differences in conclusions between studies (for recent comprehensive reviews, see [@bibr118-1759091417711512]; [@bibr2-1759091417711512]).

Indexes of Neuroplasticity {#sec12-1759091417711512}
--------------------------

The impaired postexercise facilitation of MEPs is characterized by an initial facilitation followed by an early return to the baseline MEP amplitude. This sequence has been demonstrated in both nonmedicated and medicated MDD subjects ([@bibr93-1759091417711512]; [@bibr83-1759091417711512]). These studies support the view that the motor cortex is less dynamically excitable in depressed patients and that this phenomenon may be a neurophysiological sign of an imbalance between the excitatory and inhibitory mechanisms involved in plasticity. A subsequent study revealed that this facilitation was normalized in previously depressed patients who had clinically recovered ([@bibr94-1759091417711512]).

Using a PAS protocol in a sample of 23 medicated depressed patients, [@bibr79-1759091417711512] observed that neuroplasticity was significantly lower in these patients than in age- and gender-matched healthy controls. More recently, an investigation using a PAS protocol in patients with MDD further supported this hypothesis by showing that cortical LTP-like plasticity was significantly decreased in a state-dependent manner in a group of 27 patients who suffered an acute episode of MDD. Interestingly, this study clearly showed that LTP-like plasticity was restored after remission ([@bibr56-1759091417711512]). Finally, after facilitatory PAS, changes in cortical excitability were linked to associative LTP. This connection is believed to involve glutamate signaling and the postsynaptic depolarization of cells via the activation of NMDA and α-amino-3-hydroxy-5-methylisoxazole propionate (AMPA) receptors ([@bibr99-1759091417711512]).

Vascular Depression and TMS {#sec13-1759091417711512}
---------------------------

Few data are available regarding cortical excitability in VD, and the relevant studies have not provided any evidence demonstrating overall changes in motor cortical excitability or interhemispheric asymmetry. Hence, in these patients, there is a pattern of cortical excitability that is clearly different from that in MDD, as described earlier. Moreover, the normality of CSP and SICI in VD patients indicates that the mechanisms regulating GABAergic intracortical inhibitory circuits are not involved in these individuals. These data provide a new and intriguing neurophysiological explanation for the differences in the neurobiological processes that underlie nonvascular early onset major depression and late-onset VD (Bella et al., 2011; [@bibr27-1759091417711512]; [@bibr60-1759091417711512]). Furthermore, a longitudinal study evaluated the electrophysiological changes and progression of cognitive decline in patients with subcortical cerebrovascular lesions, and the results showed that glutamate-related neuroplasticity was differentially enhanced between patients with and without VD. In particular, a high level of intracortical facilitation was observed in the nondepressed patients, and this seemed to provide a relative level of protection from cognitive and functional deterioration ([@bibr77-1759091417711512]).

Discussion {#sec14-1759091417711512}
==========

Main Findings {#sec15-1759091417711512}
-------------

The articles reviewed here provide neurophysiological evidence for altered cortical excitability ([@bibr66-1759091417711512]; [@bibr43-1759091417711512]; [@bibr62-1759091417711512]; [@bibr97-1759091417711512]; [@bibr27-1759091417711512]; [@bibr30-1759091417711512]; [@bibr105-1759091417711512]) and synaptic plasticity ([@bibr24-1759091417711512]; [@bibr4-1759091417711512]; [@bibr97-1759091417711512]; [@bibr30-1759091417711512]; [@bibr79-1759091417711512]; [@bibr56-1759091417711512]) in MDD. These data confirm the findings of previous investigations that have used different approaches ([@bibr32-1759091417711512]; [@bibr71-1759091417711512]; [@bibr101-1759091417711512]; [@bibr89-1759091417711512]; [@bibr70-1759091417711512]).

Moreover, a number of studies have shown that there is a significant decrease in postexercise facilitation in these individuals ([@bibr90-1759091417711512]; [@bibr93-1759091417711512], [@bibr94-1759091417711512]; [@bibr83-1759091417711512]; [@bibr24-1759091417711512]) that is probably linked to an imbalance between inhibitory and excitatory inputs at the level of cortical-spinal neurons. This observation, which has also been reported in schizophrenia ([@bibr83-1759091417711512]; [@bibr23-1759091417711512]), might explain the symptoms reported by these patients, which can include fatigue, weakness, motor inertia, and apathy, and indicates the existence of a potentially strong relationship between psychiatric disorders and motor output.

Finally, it should be kept in mind that changes in cortical measures of inhibition may also provide important contributions to these conditions. Accordingly, applying electroconvulsive therapy in combination with 3 Hz or 10 Hz rTMS (i.e., facilitatory rTMS) to the left prefrontal cortex of subjects with MDD led not only to clinical improvement and enhanced cortical excitability in the left motor cortex (indicated by an increased MEP/M-wave ratio and decreased motor threshold but also to the modulation of measures of GABA-mediated intracortical inhibition (i.e., shortened CSP and reduced SICI; [@bibr21-1759091417711512], [@bibr22-1759091417711512]). Taken together, these data suggest that in depressed subjects, the motor cortex is more refractory to modulatory inputs from both adjacent areas and other nonmotor areas within the CNS. Moreover, several studies have demonstrated that structural and functional abnormalities in trans-callosal connections may play crucial roles in patients with depression and other mood disorders ([@bibr4-1759091417711512]; [@bibr111-1759091417711512]; [@bibr113-1759091417711512]; [@bibr67-1759091417711512]).

In summary, when tested using TMS, both glutamatergic and GABAergic pathways seem to be impaired in MDD. Abnormal activity in the glutamatergic system that regulates synaptic plasticity is centrally important to the pathological mechanism underlying and treatment for MDD ([@bibr91-1759091417711512]). The excessive glutamatergic activation of NMDA receptors induces LTD, which may be responsible for the disruptions observed in glutamatergic receptor plasticity-related processes, including reduced motor cortex excitability and postexercise facilitation and insensitivity to PAS protocols ([@bibr90-1759091417711512]; [@bibr93-1759091417711512]; [@bibr66-1759091417711512]; [@bibr83-1759091417711512]; [@bibr43-1759091417711512]; [@bibr24-1759091417711512]; [@bibr62-1759091417711512]; [@bibr97-1759091417711512]; [@bibr27-1759091417711512]; [@bibr79-1759091417711512]).

Neurotrophin and Metaplasticity: The Contribution of Repetitive TMS {#sec16-1759091417711512}
-------------------------------------------------------------------

Another possible mechanism by which noninvasive brain stimulation techniques may operate is the modulation of neurotrophin release, which is particularly relevant in depression. It is widely accepted that brain-derived neurotrophic factor (BDNF) is implicated in neuronal survivability and the functions involved in activity-dependent synaptic plasticity, which affects dendrite complexity and spine density ([@bibr64-1759091417711512]; [@bibr39-1759091417711512]). Exposure to stress decreases BDNF expression in the hippocampus and PFC, and different studies have shown that there is a deficit of this neurotrophin in depressed patients. These data further support the concept that dysfunctional neuroplasticity contributes to both mood and cognitive disorders ([@bibr78-1759091417711512]; [@bibr55-1759091417711512]; [@bibr64-1759091417711512]; [@bibr39-1759091417711512]). In this regard, rTMS has been shown to increase serum BDNF concentrations in depressed patients ([@bibr114-1759091417711512]) and to improve refractory depression by influencing the release of catecholamines and BDNF ([@bibr112-1759091417711512]). Finally, applying low-frequency rTMS in model rats with vascular dementia improved learning and memory, protected pyramidal cells from apoptosis, and promoted hippocampal plasticity by increasing *Bcl-2* expression and reducing *Bax* expression ([@bibr110-1759091417711512]).

Finally, relatively little is currently known regarding aberrant metaplasticity phenomena in mood disorders or other neuropsychiatric diseases. It is widely accepted that metaplasticity is necessary to modulate the excitability and functions of neuronal networks. Hence, the modulation of metaplasticity might increase or even restore the innate ability of neurons to exhibit synaptic plasticity under pathological conditions. Based on the recently introduced concept of "interhemispheric rivalry" in stroke, several studies have used a "priming" protocol to enhance recovery in stroke survivors ([@bibr38-1759091417711512]). The application of a protocol including TBS or QPS may be useful for modulating brain regions exhibiting disrupted plasticity in depressed subjects.

Limitations and Critical Aspects {#sec17-1759091417711512}
--------------------------------

Although TMS provides exciting insights into different aspects of neural excitability and plasticity, the following limitations and aspects critical to both the techniques and designs or methodologies used in different studies should be taken into account: as previously shown, the spatial resolution of TMS is more limited than that of neuroimaging techniques, even when a figure-eight-shaped coil is used;an absence of changes in TMS measures does not necessarily rule out the presence of subtle neuroplastic changes;TMS is primarily useful for assessing the motor cortex, which is not always the most-involved area in patients with depression or other psychiatric disorders; generalizing findings from motor to nonmotor areas therefore requires caution, although TMS has been shown to reliably probe the excitability and connectivity of both motor and nonmotor cortical-subcortical networks ([@bibr84-1759091417711512]);there is a degree of variability in the results of the studies reviewed here that might be explained by the heterogeneous phenotypes of the included affective disorders and the diagnostic overlap among them;the depressed patients included in the studies were often on antidepressant medications and other psychotropic drugs that may have affected TMS measures of excitability and plasticity. Furthermore, only a few studies have evaluated patients in a remission state, and it is therefore difficult to determine whether neuroplasticity may be an underlying pathophysiological mechanism of the disease or a state-dependent phenomenon.finally, although the hypothesis that disrupted synaptic plasticity contributes to depression may open paths to novel TMS-driven drugs, very few such studies have so far been carried out.

Conclusions {#sec18-1759091417711512}
-----------

Studying cortical excitability and synaptic plasticity using TMS may lead to new insights into the electrophysiology and neurochemistry underlying a wide spectrum of depressive disorders. The observed TMS patterns may indicate the different pathological substrates of neuropsychiatric diseases and explain some symptoms, such as fatigue and motor inertia, which are frequently reported in depressed patients. In the near future, interventions aimed at enhancing neuroplasticity should merit special attention. Particular consideration should be given to the role of noninvasive brain stimulation techniques, the genetic profiles of subjects, and the pharmacological effects of drugs that act on multiple neurotransmission pathways.

Summary statement {#sec19-1759091417711512}
=================

Transcranial magnetic stimulation sheds light on the *in vivo* neurochemical mechanisms underlying cortical plasticity in patients with major depression.
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[^1]: *Note.* TMS = transcranial magnetic stimulation; rTMS = repetitive TMS; M = male; F = female; SD = standard deviation; R = right hemisphere; L = left hemisphere; Y = yes; N = no; MDD = Major Depressive Disorder; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders -- Fourth Edition; DSM-IV-TR = DSM -- Fourth Edition -- Text Revision; DSM-V = DSM -- Fifth Edition; K-SADS-PL = Kiddie-Sads-Present and Lifetime Version; CDRS-R = Children's Depression Rating Scale--Revised; rMT = resting motor threshold; CSP = cortical silent period; iSP = ipsilateral silent period; SICI = short-latency afferent inhibition; ICI = intracortical inhibition; ICF = intracortical facilitation; CMCT = central motor conduction time; GABA = gamma-aminobutyric acid; VD = patients with vascular depression; VCI-ND = patients with vascular cognitive impairment -- no dementia; NR = not reported; ▴ = increase/enhancement; ▾ = decrease/reduction; ▪ = no significant change.

[^2]: *Note.* TMS = transcranial magnetic stimulation; rTMS = repetitive TMS; PAS = paired-associative stimulation; M = male; F = female; SD = standard deviation; Y = yes; N = no; MDD = Major Depressive Disorder; DSM-III-TR = Diagnostic and Statistical Manual of Mental Disorders -- Third Edition -- Text Revision; DSM-IV = DSM -- Fourth Edition; DSM-IV-TR = DSM -- Fourth Edition -- Text Revision; K-SADS-PL = Kiddie-Sads-Present and Lifetime Version; CDRS-R = Children's Depression Rating Scale--Revised; ICD-10 = International Statistical Classification of Diseases and Related Health Problems -- Tenth revision; LTP = long-term potentiation; dlPFC = dorsolateral prefrontal cortex; M1 = primary motor cortex; rMT = resting motor threshold; NR = not reported; ▴ = increase/enhancement; ▾ = decrease/reduction; ▪ = no significant change.
